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Non-cell-autonomyDuring early mouse embryogenesis, multiple patterning and differentiation events require the activity of
Nodal, a ligand of the transforming growth factor-beta (TGFβ) family. Although Nodal signaling is known to
require activity of EGF-CFC co-receptors in many contexts, it has been unclear whether all Nodal signaling in
the early mouse embryo is EGF-CFC dependent. We have investigated the double null mutant phenotypes for
the EGF-CFC genes Cripto and Cryptic, which encode co-receptors for Nodal, and have found that they have
partially redundant functions in early mouse development. Expression of Cripto and Cryptic is non-
overlapping prior to gastrulation, since Cripto is expressed solely in the epiblast whereas Cryptic is expressed
in the primitive endoderm of the late blastocyst and the visceral endoderm after implantation. Despite these
non-overlapping expression patterns, Cripto; Cryptic double mutants display severe defects in epiblast,
extraembryonic ectoderm, and anterior visceral endoderm (AVE), resulting in phenotypes that are highly
similar to those of Nodal null mutants. Our results indicate that both Cripto and Cryptic function non-cell-
autonomously during normal development, and that most if not all Nodal activity in early mouse
embryogenesis is EGF-CFC-dependent.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.The Nodal signaling pathway plays a central role in patterning the
mouse embryo from pre-gastrulation through early somite stages. In
particular, Nodal signaling is required for speciﬁcation of the anterior–
posterior and left–right body axes, as well as formation of the primary
germ layers (reviewed in Schier, 2003; Schier and Shen, 2000; Shen,
2007; Whitman, 2001). Furthermore, recent studies have demon-
strated that Nodal signaling plays critical roles in multiple patterning
and differentiation events at pre-gastrulation stages of development
(Brennan et al., 2001; Guzman-Ayala et al., 2004; Mesnard et al.,
2006).
Following embryo implantation, Nodal is expressed in the epiblast,
and mediates reciprocal interactions between the epiblast as well as
two adjoining extraembryonic tissues: the visceral endoderm and
extraembryonic ectoderm (ExE). Null mutants for Nodal display
severe defects in all three of these tissues. In the epiblast, Nodal
mutants display decreased expression of pluripotency markers,
suggesting that Nodal signaling is required to maintain the undiffer-
entiated state of the epiblast (Brennan et al., 2001; Mesnard et al.,
2006). In the visceral endoderm, Nodal signaling is required for the
speciﬁcation of the distal visceral endoderm (DVE) as well as its
subsequent translocation to the prospective anterior side, thereby
establishing the anterior–posterior axis (Brennan et al., 2001; Norrisand Robertson, 1999). In the ExE, Nodal signaling is essential for
maintenance of the ExE and prevents differentiation of trophoblast
stem cells (Brennan et al., 2001; Guzman-Ayala et al., 2004).
Nodal signaling is mediated by an Activin receptor complex
composed of a dimer of the type I serine-threonine receptor ALK4
(ActRIB) and a dimeric type II Activin receptor, either ActRII or
ActRIIB. Following receptor activation, Smad2 and/or Smad3 are
phosphorylated and accumulate together with Smad4 in the nucleus
to mediate transcriptional responses (Yan et al., 2002; Yeo and
Whitman, 2001) together with the FoxH1 (FAST) winged-helix
transcription factor (Chen et al., 1996, 1997), as well as members of
the Mixer subfamily of homeodomain proteins (Germain et al., 2000).
The Nodal pathway differs from that for Activin in that Nodal signaling
requires the activity of EGF-CFC co-receptors (Reissmann et al., 2001;
Yan et al., 2002; Yeo and Whitman, 2001), whereas Activin does not
require a co-receptor for its signaling activity (Gritsman et al., 1999;
Kumar et al., 2001; Yan et al., 2002). EGF-CFC co-receptors are small
cysteine-rich extracellular proteins that are attached to the cell
membrane by a glycosyl-phosphatidylinositol (GPI) linkage (Shen,
2007; Shen and Schier, 2000; Wechselberger et al., 2005). Two
EGF-CFC genes are present in the mammalian genome, Cripto and
Cryptic, while a varying number is present in other vertebrate species,
including the single zebraﬁsh gene, one-eyed pinhead (oep).
A central question regarding the function of EGF-CFC proteins has
been whether they are essential for all aspects of Nodal signaling, as
originally indicated by studies in the zebraﬁsh (Gritsman et al., 1999).
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deﬁnitive on this issue. Although Cripto and Cryptic single mutants
both display phenotypes associated with defects in Nodal signaling, it
has been unclear whether all Nodal functions correspond to speciﬁc
requirements for these EGF-CFC genes. Null mutants for Cripto lack
embryonic mesoderm and deﬁnitive endoderm, and are defective in
anterior translocation of the distal visceral endoderm (DVE) (Ding et
al., 1998; Xu et al., 1999). In contrast, Cryptic null mutants survive
until birth and display severe left–right laterality defects, but do not
exhibit phenotypes associated with pre-gastrulation patterning and
differentiation (Gaio et al., 1999; Yan et al., 1999). Thus, to a ﬁrst
approximation, Cripto is required for early Nodal functions prior to
and including gastrulation, whereas Cryptic is required for later Nodal
requirements in left–right speciﬁcation.
However, null mutants for Cripto and Nodal display signiﬁcant
differences in their phenotypes (Brennan et al., 2001; Ding et al.,
1998; Mesnard et al., 2006), indicating that some Nodal signaling
activity is retained in the absence of Cripto. In particular, Cripto is only
expressed in the epiblast, not the visceral endoderm or the ExE, and
chimeras with a wild-type visceral endoderm and Cripto mutant
epiblast still display a Cripto null phenotype (Ding et al., 1998; Kimura
et al., 2001). Given that Cripto functions as a Nodal co-receptor, these
observations have led to suggestions that Nodal signaling in the
visceral endoderm and ExE may not require EGF-CFC activity (Ben-
Haim et al., 2006; Liguori et al., 2008). For example, it has been
proposed that signaling by the Nodal precursor from the epiblast to
the ExE for maintenance of BMP4 expression is Cripto-independent,
and possibly EGF-CFC independent as well (Ben-Haim et al., 2006).
Similarly, the ability of a Cerberus-like (Cerl) null mutant to partially
rescue the Cripto null phenotype has been interpreted as reﬂecting
EGF-CFC-independent Nodal signaling (Liguori et al., 2008). Alterna-
tively, these observations raise the possibility that Cryptic may have
earlier functions than previously recognized, and also mediates Nodal
signaling during early mouse embryogenesis.
In the studies described below, we show that in the absence of
Cripto, there is an essential role for Cryptic in maintenance of the
pluripotent epiblast and the extraembryonic ectoderm as well as
formation of the distal visceral endoderm. Our ﬁndings suggest that
EGF-CFC genes are essential for most if not all known aspects of Nodal
function in the early mouse embryo.
Materials and methods
Mouse strains and genotyping
The Cripto null allele and Cryptic null allele used in this study have
been previously described (Ding et al., 1998; Yan et al., 1999). The
Nodal-lacZmice (Collignon et al., 1996) were generously provided by
Liz Robertson.
Genotypes of 5.5, 6.5 and 7.5 dpc whole-mount embryos were
determined by PCR using genomic DNA from embryo lysates. Embryos
following in situ hybridization were similarly genotyped except that a
45-cycle PCR program was used. Genotypes of embryo sections were
deduced based on the strict correlation between the mutant
phenotypes and their genotypes. PCR primers used were: Cripto
wild-type (forward) 5′-ACC TGC CCC ATG ACT TCT CTT ACA-3′,
(reverse) 5′-CCC TGC TGC CCT TAT GCT ATT TTA-3′; Cripto mutant
(forward) 5′-CCA TCC CCT GCC CGT CTA CAC G-3′, (reverse) 5′-GTC
ACG CAA CTC GCC GCA CAT-3′; Cryptic wild-type (forward) 5′-TTC
CTG ACT CCA GCA CTT TGGGA-3′, (reverse) 5′-GGC TGA AAAACA AGT
TAG CAG G-3′; Cryptic mutant (forward) 5′-GTG GGG GTG GGG TGG
GAT TAG AT-3′, (reverse) 5′-CCT CTG TTT TTG GTG ACT GTC GC-3′;
Nodal wild-type (forward) 5′-CCA CTC ACC ATT GAC ATT TTC CAC
CAG-3′, (reverse) 5′-TGG ATG TAG GCA TGG TTG GTA GGA TG-3′;
Nodal mutant (forward) 5′-ATA CTG CAC CGG GCG GGA AGG AT-3′,
(reverse) 5′-CCG CGC TGT ACT GGA GGC TGA AG-3′.Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as previously
described (Shen et al., 1997). Mouse probes were as follows: Afp
(Tilghman et al., 1979); Bmp4 (Winnier et al., 1995); Cer1 (Cerberus-
like) (Belo et al., 1997); Cdx2 (Strumpf et al., 2005); Cripto (Ding et al.,
1998); Cryptic (Shen et al., 1997); Hex (Hhex) (Thomas et al., 1998);
Lefty1 (Meno et al., 1997); Lhx1 (Shawlot and Behringer, 1995);
Mash2 (Guillemot et al., 1994); and Nanog (Chambers et al., 2003).
The Oct4 probe corresponded to a 1.0 kb HindIII–AccI fragment
ampliﬁed from ES cell cDNA and cloned into pBluescript SK. All
embryos were genotyped following in situ hybridization and
photography, except for the embryos used for sectioning.
Results
Non-overlapping expression of Cripto and Cryptic in the pre-gastrulation
embryo
To investigate the potential redundant functions of Cripto and
Cryptic, we ﬁrst compared their expression at peri-implantation and
pre-gastrulation stages of embryogenesis by whole-mount in situ
hybridization (Fig. 1). In the blastocyst at 3.5 days post coitum (dpc),
Cripto expression can be detected in the inner cell mass, but not the
trophectoderm (Fig. 1A). Expression of Cripto is later found in the
epiblast, but not the primitive endoderm or trophectoderm of the peri-
implantation embryo at 4.5 dpc (Fig. 1B). At post-implantation stages,
Cripto is expressed uniformly in the epiblast at 5.5 dpc, but not in the
visceral endoderm or ExE, and is subsequently localized to the proximal
epiblast at 6.0 dpc and posterior epiblast and nascent mesoderm at
6.75 dpc (data not shown), aswe have previously described (Ding et al.,
1998).
In the case of Cryptic, we found that expression is ﬁrst observed in
nascent primitive endoderm cells at 4.0 dpc (Fig. 1E). Cryptic
expression continues in the primitive endoderm and newly formed
parietal endoderm of the peri-implantation and early post-implanta-
tion embryo at 4.5 and 4.75 dpc (Figs. 1F–H). Expression of Cryptic is
subsequently found at low levels in the visceral endoderm around the
embryonic–extraembryonic boundary at 5.5 dpc (Fig. 1I), and is
subsequently up-regulated in the proximal embryonic visceral
endoderm and distal extraembryonic visceral endoderm (Fig. 1J).
Interestingly, Cryptic expression is not uniform within the embryonic
visceral endoderm, but instead is expressed preferentially in the
anterior visceral endoderm (AVE) (Figs. 1J, K). At early-mid streak
stages of gastrulation, Cryptic is expressed in nascent mesoderm that
will contribute to the axial and lateral mesoderm (Figs. 1K, M),
consistent with our previous ﬁndings (Shen et al., 1997). Notably,
Cryptic expression is never observed in the epiblast before gastrula-
tion or in the ExE (Figs. 1I–K, M, N).
These results indicate that the expression patterns of Cripto and
Cryptic do not overlap prior to mesoderm formation. Notably, Cripto
expression in Cryptic null mutants (n=2) is indistinguishable from that
inwild-typeembryos prior to andduringgastrulation (Figs. 1C, D) (Ding
et al., 1998). Similarly, Cryptic continues to be expressed in Cripto null
mutants (n=2) at these stages, although Cryptic expression is radially
symmetric in the visceral endoderm, consistent with the lack of a
properly positioned AVE in Criptomutants (Figs. 1L, O). Therefore, there
is no evidence for compensatory expression of either Cripto or Cryptic in
the absence of function for the other gene.
Severe post-implantation lethal phenotype of Cripto; Cryptic double
mutants
To investigate EGF-CFC functions in pre-gastrulation development,
we analyzed the phenotypes of compound mutants for Cripto and
Cryptic in intercrosses ofCripto+/−; Cryptic+/−doubleheterozygotes.At
Fig. 1. Expression of Cripto and Cryptic in mouse embryos at 3.5 to 6.75 days post coitum (dpc). (A–D) Cripto expression in wild-type (A, B) and Cryptic null mutant (C, D) embryos.
(A) Expression of Cripto in thewild-type blastocyst at 3.5 dpc is restricted to the inner cellmass, and is not found in the trophectoderm. (B) Cripto expression is restricted to the epiblast at
4.5 dpc, and is not found in the primitive endoderm. (C, D) Expression of Cripto in the proximal epiblast of a Cryptic nullmutant at 6.0 dpc (C) and in the posterior epiblast at 6.5 dpc (D) is
indistinguishable from thewild-type pattern (Ding et al., 1998). In panel D, proximal (P) and distal (D) are indicated. (E–O) Expression of Cryptic in wild-type (E–K,M, N) and Cripto null
mutant (L, O) embryos. (E) Cryptic expression in cells of the nascent primitive endoderm (arrow) at 4.0 dpc. (F, G) Expression of Cryptic in the primitive endoderm and newly formed
parietal endoderm at 4.5 dpc (F) and 4.75 dpc (G). (H) Longitudinal section of the embryo in (G), showing absence of expression in the epiblast; nuclei are counterstained with methyl
green. (I) Cryptic expression at 5.5 dpc in the proximal visceral endoderm at the level of the boundary between extraembryonic ectoderm and epiblast (arrowheads). (J) Expression of
Cryptic at 6.0 dpc in the proximal visceral endoderm, including the anterior visceral endoderm; the junction between extraembryonic ectoderm and epiblast is indicated (arrowheads);
proximal (P) and distal (D) are indicated. (K) Cryptic expression in the embryonic and extraembryonic visceral endoderm at 6.75 dpc, including the anterior visceral endoderm.
(L) Expression of Cryptic in the visceral endoderm is unaltered in a Cripto−/− embryo at 6.5 dpc. (M, N) Cross-sections of the embryo at the indicated levels in (K), showing Cryptic
expression in the anterior visceral endoderm, and low-level expression in the visceral endoderm and nascent mesoderm. (O) Cross-section of the embryo in (L). Scale bars correspond to
100 µm. Abbreviations: ave, anterior visceral endoderm; epi, epiblast; exe, extraembryonic ectoderm; icm, inner cell mass; mes, mesoderm; par, parietal endoderm; pe, primitive
endoderm; ps, primitive streak; tro, trophectoderm; ve, visceral endoderm.
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recovered in Mendelian ratios (Table 1). Morphological examination of
the Cripto−/−; Cryptic−/− double mutant embryos at 5.5 dpc showed
that they have a reduced ExE as well as thickened visceral endoderm
relative towild-type aswell as Cripto−/− singlemutants (Figs. 2A, B, D);
interestingly, Cripto−/− mutants also showed a slightly smaller ExE
relative to wild-type (Figs. 2A, B). At 6.5 dpc, Cripto−/−; Cryptic−/−
doublemutants lack any evidence of an anterior visceral endoderm, and
are signiﬁcantly smaller than theirwild-type orCripto−/− singlemutant
littermates (Figs. 2G, H, J). By 7.5 dpc, Cripto−/−; Cryptic−/− embryos
are highly abnormal, lacking mesoderm formation or evidence of
anterior-patterning, and are in the process of resorbing (Figs. 2M, N, P).
Unexpectedly, however, we also found that Cripto−/−; Cryptic+/−embryoswere phenotypically similar to Cripto−/−; Cryptic−/− embryos
(Table 2; Figs. 2C, I, O), indicating the haploinsufﬁciency of Cryptic in the
absence of Cripto function; in contrast, Cripto+/−; Cryptic−/− embryos
were phenotypically normal. Furthermore, the phenotypes of both
Cripto−/−; Cryptic−/− and Cripto−/−; Cryptic+/− embryos were
remarkably similar to that ofNodal−/−mutants at each stage examined
(Figs. 2E, K, Q). Notably, the Cripto−/−; Cryptic−/− and Cripto−/−;
Cryptic+/− double mutants at 6.5 dpc display an accumulation of
visceral endoderm tissue at the distal tip that is characteristic of Nodal
mutants (Figs. 2I–K).
Given the severe epiblast defects observed in the Cripto−/−; Cryptic−/
− double mutants, wemeasured the total length of embryos arising from
Cripto+/−; Cryptic+/− intercrosses, as well as for Nodal−/− mutants. In
Table 1
Genotypes recovered from Cripto+/−; Cryptic+/− intercrosses at 5.5 dpc.
Genotype Recovered Expected
Cripto+/+; Cryptic+/+ 3 4.75
Cripto+/+; Cryptic+/− 9 9.5
Cripto+/+; Cryptic−/− 5 4.75
Cripto+/−; Cryptic+/+ 9 9.5
Cripto+/−; Cryptic+/− 20 19
Cripto+/−; Cryptic−/− 12 9.5
Cripto−/−; Cryptic+/+ 5 4.75
Cripto−/−; Cryptic+/− 6 9.5
Cripto−/−; Cryptic−/− 7 4.75
Totals 76
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proximal-distal axis from the distal tip to the base of the ectoplacental
cone, followed by genotyping of the embryos examined (Fig. 2F, L, R).
(Because Cripto−/−; Cryptic−/− or Cripto−/−; Cryptic+/− embryos have
similar phenotypes, these genotypes were grouped together as “Cripto;
Cryptic” embryos). Notably, we found that the embryo lengths of Cripto;
Crypticdoublemutantsweresigniﬁcantly shorter than thatofwild-typeor
Cripto−/− single mutants from 5.5 to 7.5 dpc (Pb0.01 for both
comparisons at all three stages examined), and were similar to those of
Nodal−/− single mutants at both 6.5 and 7.5 dpc. These ﬁndings indicate
that the overall phenotype of Cripto; Cryptic double mutants is more
severe than that of Cripto single mutants and is comparable to that of
Nodalmutants.Fig. 2.Morphology and epiblast length of Cripto; Cryptic double mutants relative to wild-typ
dashed lines indicate boundary between epiblast and visceral endoderm. (G–K) Embryos of
endoderm. (M–Q) Embryos of the indicated genotypes at 7.5 dpc; arrow in N indicates expa
correspond to 100 µm. (F, L, R) Box and whiskers plot of embryo length, measured from the
5.5, 6.5 and 7.5 dpc. Embryos of Cripto−/−; Cryptic−/− and Cripto−/−; Cryptic+/− genotypes
epc, ectoplacental cone; epi, epiblast; exe, extraembryonic ectoderm; ps, primitive streak;Requirement of Cripto and Cryptic for epiblast and extraembryonic
ectoderm maintenance
Based on the defects identiﬁed in our morphological analyses, we
examined expression of epiblast-speciﬁc markers by in situ hybridiza-
tion. The pluripotencymarker Oct4 is expressed in wild-type epiblast at
5.5 and6.5 dpc (Rosner et al., 1990), but is down-regulated inCripto−/−;
Cryptic−/− double mutants at 5.5 dpc (n=2) and is absent by 6.5 dpc
(n=6) (Figs. 3A, C, D, F). Interestingly, Oct4 expression in Cripto−/−
single mutants is relatively normal at 5.5 dpc (n=3), but is also down-
regulated or absent at 6.5 dpc (n=4; 3 embryos lackedOct4 expression,
1 embryo showed decreased expression) (Figs. 3B, E; data not shown).
Furthermore, we found that Nanog expression in the posterior epiblast
at 6.5 dpc (Morkel et al., 2003) is down-regulated in Cripto−/−mutants
(n=3), and is absent in Cripto−/−; Cryptic−/− double mutants (n=3)
(Figs. 3G–I). These ﬁndings are consistent with a severe epiblast defect
in Cripto−/−; Cryptic−/− double mutants.
To assess the maintenance and differentiation of the ExE, we ﬁrst
examined the expression of Bmp4, whichmarks the ExE proximal to the
epiblast in wild-type embryos (Fig. 4A) (Coucouvanis and Martin,
1999). In Cripto−/− single mutants, the domain of Bmp4 expression in
the ExE is reduced in size at 5.5 dpc, but is positioned correctly in
relationship to the epiblast (n=6) (Fig. 4B). However, in Cripto−/−;
Cryptic−/− double mutants, Bmp4-positive cells are found lateral or
distal to the epiblast, indicating a disrupted proximal-distal axis (n=3)
(Fig. 4C). Notably, a similar expression pattern is observed in Nodal−/−
mutants (n=4) (Fig. 4D) as well as Smad2−/−mutants (Waldrip et al.,
1998). At 6.5 dpc,Bmp4expression is reducedor absent in theCripto−/−e, Cripto, and Nodal null mutants. (A–E) Embryos of the indicated genotypes at 5.5 dpc;
the indicated genotypes at 6.5 dpc; arrows in I–K indicate regions of thickened visceral
nded neuroectoderm that is typical of Cripto−/−mutants (Ding et al., 1998). Scale bars
base of the ectoplacental cone to the distal tip, in embryos of the indicated genotypes at
are grouped together as Cripto; Cryptic. Abbreviations: ave, anterior visceral endoderm;
ve, visceral endoderm.
Table 2
Genotypes of abnormal embryos from Cripto+/−; Cryptic+/− intercrosses.
Genotype 5.5 dpca 6.5 dpc 7.5 dpc
Recovered Expected Recovered Expected Recovered Expected
Cripto−/−;
Cryptic+/+
5 4.75 3 2.7 3 2.6
Cripto−/−;
Cryptic+/−
6b 9.5 6b 5.4 4b 5.2
Cripto−/−;
Cryptic−/−
7 4.75 3 2.7 7 2.6
Other 58 57 31 32.2 28 31.5
Totals 76 43 42
a Data taken from Table 1.
b Phenotype similar to that of Cripto−/−; Cryptic−/− mutants.
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reduced but correctly positioned expression), and is completely absent
in Cripto−/−; Cryptic−/− double mutants (n=3) (Figs. 4E–H). As is the
case for Bmp4, expression of Cdx2 in the distal ExE at 6.5 dpc (Beck et al.,
1995) is reduced or absent in Cripto−/− single mutants (n=4; 2
embryos lacked Cdx2 expression, and 2 showed reduced but correctly
patterned expression), and is completely lost in Cripto−/−; Cryptic−/−
doublemutants (n=5), similar toNodal−/−mutants (n=2) (Figs. 4I–L;
data not shown).
Next, we examined the expression of Mash2, which marks differen-
tiating trophoblast cells of the ectoplacental cone in wild-type embryos
(Figs. 4M, P) (Guillemot et al., 1994). We found that the Mash2
expression domain is greatly expanded into the ExE region in putative
Cripto; Cryptic doublemutants at 6.5 dpc (n=2) (Figs. 4O, R), in contrast
with the relatively normal expression pattern in putative Cripto single
mutants (n=3) (Figs. 4N, Q). (Note that embryo genotypes were
deduced from their phenotypes in this experiment since the embryos
were sectioned and not genotyped; thus, Cripto; Cryptic double mutants
may correspond to eitherCripto−/−; Cryptic−/− andCripto−/−; Cryptic+/
− genotypes.) Overall, these data on marker expression in the ExE are
consistent with an inability to maintain the population of trophoblast
stem cells, which instead differentiate towards an ectoplacental cone
fate; a similar phenotype was previously reported for Nodal mutants
(Guzman-Ayala et al., 2004).Fig. 3. Expression of epiblast markers in wild-type, Cripto, and Cripto; Cryptic mutants.
(A–C) Expression of Oct4 at 5.5 dpc; note the down-regulation in the Cripto−/−; Cryptic−/−
double mutant (arrow). (D–F) Oct4 is expressed at 6.5 dpc in the wild-type epiblast (D), but
not in the Cripto−/− or Cripto−/−; Cryptic−/− mutants (E, F). (G–I) Expression of Nanog at
6.5 dpc is down-regulated in the Cripto−/−mutant, but is absent in theCripto−/−; Cryptic−/−
double mutant. Nanog expression is localized to the posterior epiblast in the wild-type
embryo (G), but is proximally localized in the Cripto−/− mutant (arrow in H), which lacks
anterior–posteriorpolarity. Scale bars correspond to100 µm.Abbreviations: epi, epiblast; exe,
extraembryonic ectoderm; ve, visceral endoderm.EGF-CFC function in visceral endoderm
Finally, we examined the formation of the anterior visceral
endoderm (AVE) in Cripto; Cryptic doublemutants. First, we examined
the expression of Cerberus-like (Cerl), which marks the AVE in wild-
type embryos at 6.5 dpc, and found that expression was completely
absent in Cripto−/−; Cryptic−/− double mutants (n=2) (Figs. 5A, D).
Interestingly, we found that Cripto−/− single mutants display
heterogeneous Cerl expression, with some embryos expressing Cerl
in the distal visceral endoderm (n=2), and others with no detectable
Cerl expression (n=3) (Figs. 5B, C). Similarly, Hex expression also
marks the AVE in wild-type embryos at 6.5 dpc (Fig. 5H) (Thomas et
al., 1998), but is lost in Cripto−/−; Cryptic−/− double mutants (n=4),
and displays expression in the distal visceral endoderm (n=2) or is
completely absent (n=4) in Cripto−/− single mutants (Figs. 5I–K).
Based on these ﬁndings, we further examined the visceral
endoderm phenotype of Cripto; Cryptic double mutants as well as
Cripto−/− and Cryptic−/− single mutants at 5.5 dpc. We found that
expression of Cerl was not detectable in the distal visceral endoderm
(DVE) of Cripto−/− mutants (n=5), and was absent in Cripto−/−;
Cryptic−/− double mutants (n=2) (Figs. 5E–G). However, expression
of alpha-fetoprotein (Afp) remains present in the embryonic visceral
endoderm of Cripto−/−mutants at 5.5 dpc, although the expression in
the extraembryonic visceral endoderm is lost (n=2) (Figs. 5L, M); in
Cripto−/−; Cryptic−/− double mutants, Afp expression is completelyabsent (n=2) (Fig. 5N). Furthermore, expression of the DVE marker
Lefty1 is also absent in Cripto−/−mutants (n=4) as well as Cripto−/−;
Cryptic−/− double mutants (n=2) (Figs. 5O, P, R), consistent with the
previously reported absence of Lefty1 expression in Cripto−/−
mutants at 6.5 dpc (Kimura et al., 2001). In contrast, Lefty1 expression
in the DVE appears normal in Cryptic−/− single mutants (Fig. 5Q), as
expected from their wild-type phenotype at early embryonic stages.
Finally, Lhx1 is broadly expressed in the embryonic visceral endoderm
of wild-type embryos at 5.5 dpc (Perea-Gomez et al., 1999), yet its
expression is absent in Cripto−/− mutants (n=3) (Figs. 5S, T).
These ﬁndings indicate that speciﬁcation of the DVE and more
broadly the embryonic visceral endoderm requires EGF-CFC function
prior to 5.5 dpc, consistent with a previously described role of Nodal
in this process (Mesnard et al., 2006). Interestingly, there is a
signiﬁcant role for Cripto in this requirement for EGF-CFC function,
even though Cripto is not expressed in the visceral endoderm.
Furthermore, since Cer1, Lefty1, and Lhx1 are believed to be directly
or indirectly regulated by Nodal signaling, our results suggest that
EGF-CFC genes are essential in specifying the DVE through the Nodal
signaling pathway.
Discussion
Taken together, our analyses have demonstrated that partially
redundant activities of the EGF-CFC genes Cripto and Cryptic play
Fig. 4. Expression of extraembryonic ectoderm (ExE) and ectoplacental cone markers in wild-type, Cripto, and Cripto; Crypticmutants. (A–D) Bmp4 is expressed at 5.5 dpc in the ExE
of wild-type (A), but is found only in the most distal part of the ExE in Cripto−/− mutants (B). Expression of Bmp4 is severely mislocalized in the presumptive epiblast (arrows) of
Cripto−/−; Cryptic−/− double mutants (C) as well as Nodal−/− mutants (D). (E–H) At 6.5 dpc, Bmp4 is expressed in the distal ExE in wild-type (E), but is either reduced or nearly
absent in Cripto−/− single mutants (arrows in F, G), and is lost entirely in Cripto−/−; Cryptic−/− double mutants (H). (I–L) Expression of Cdx2 at 6.5 dpc in the ExE in wild-type (I) is
nearly normal in Cripto−/−mutants (J), but is absent in both Cripto−/−; Cryptic−/− double mutants (K) and Nodal−/−mutants (L). (M–O) Expression ofMash2 in the ectoplacental
cone of wild-type (M), putative Criptomutant (N) and putative Cripto; Cryptic double mutant (O) embryos, showing an expanded domain ofMash2 expression in the double mutant.
(P–R) Longitudinal sections of the embryos shown in M–O, respectively; nuclei are counterstained with methyl green. In M–R, embryo genotypes were deduced from phenotypes,
and the Cripto; Cryptic double mutant may correspond to either Cripto−/−; Cryptic−/− and Cripto−/−; Cryptic+/− genotypes. Scale bars correspond to 100 µm. Abbreviations: epc,
ectoplacental cone; epi, epiblast; exe, extraembryonic ectoderm.
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Cripto; Cryptic double mutant phenotype is highly similar to that for
Nodal null mutants, indicating that EGF-CFC function is required for
most or all Nodal signaling during early embryogenesis. As is the casefor Nodal, the combined functions of EGF-CFC genes are required for
maintenance of the epiblast and ExE, as well as for formation of the
DVE. However, the expression patterns of Cripto and Cryptic do not
overlap in any of these tissues during pre-gastrulation development,
Fig. 5. Expression of visceral endodermmarkers in wild-type, Cripto, Cryptic, and Cripto; Crypticmutants. (A–D) At 6.5 dpc, Cerl is expressed in wild-type embryos in the anterior visceral endoderm (A), but is either mislocalized distally or absent in
Cripto−/−mutants (B, C), and is completely lost in Cripto−/−; Cryptic−/− double mutants (D). (E–G) At 5.5 dpc, Cerl is expressed in the distal visceral endoderm in wild-type embryos (E), but is absent in both Cripto−/−mutants and Cripto−/−;
Cryptic−/−doublemutants (F,G). (H–K)ExpressionofHex at 6.5 dpc is found in thewild-type anterior visceral endoderm(H), but is eithermislocalizeddistallyor is lost inCripto−/−mutants (I, J), and is absent inCripto−/−; Cryptic−/−doublemutants
(K). (L–N) Afp (alpha-fetoprotein) is broadly expressed in the embryonic visceral endoderm (overlying the epiblast) and distal extraembryonic visceral endoderm (overlying the ExE) of wild-type embryos at 5.5 dpc (L), but is limited to the distal
embryonic visceral endoderm in Cripto−/−mutants (M) and is absent in Cripto−/−; Cryptic−/− doublemutants (N). (O–R) Lefty1 is expressed in the distal visceral endoderm at 5.5 dpc in wild-type as well Cryptic−/−mutants (O, Q), but is absent in
Cripto−/−mutants and Cripto−/−; Cryptic−/− double mutants (P, R). (S, T) Lhx1 is expressed in thewild-type embryonic visceral endoderm at 5.5 dpc (S), but is absent in Cripto−/−mutants (T). Scale bars correspond to 100 µm. Abbreviations: ave,
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non-cell-autonomous function.
Non-autonomous EGF-CFC function
The existence of two EGF-CFC genes in mammalian genomes and
only one gene (oep) in zebraﬁsh suggests that Cripto and Cryptic
originated from a common ancestor and subsequently acquired
functional divergency. However, our studies have shown that these
two EGF-CFC genes retain common redundant functions, and that in
the absence of Cripto, Cryptic is haploinsufﬁcient. In addition, we have
observed a defect in maintenance of pluripotent marker expression in
Cripto null mutants alone, consistent with the previously described
premature neural differentiation of epiblast (Ding et al., 1998; Kimura
et al., 2001; Liguori et al., 2003); a similar phenotype has been
described for Nodal mutants (Camus et al., 2006; Lu and Robertson,
2004; Mesnard et al., 2006).
Previous studies have shown that Cripto mutants form a partially
functional DVE that fails to translocate, based on the expression of Hex
and Cerl in the distally mispositioned AVE at 6.75 dpc (Ding et al.,
1998). In the present work, we observe that this mispositioning of Hex
and Cerl expression in the distal visceral endoderm is heterogeneous
in Cripto mutants, with some embryos lacking expression altogether;
similar heterogeneity was found for marker expression in the epiblast
and ExE. This phenotypic heterogeneity may be due to a different
strain background from our previous study, since the Cripto mutant
mice have now been backcrossed extensively against C57BL/6 in our
laboratory. In addition, our data suggest that expression of Cer1 may
be developmentally delayed in Cripto mutants, since it was not
detected at 5.5 dpc. Thus, the failure of DVE movement in Cripto
mutants may be due at least in part to the absence of Lefty1 and Cer1Fig. 6.Model for non-autonomous redundant functions of Cripto and Cryptic. Schematic diag
Cryptic double mutant embryos at 5.5 and 6.75 dpc. Suggested pathways of Nodal and EGF-C
5.5 dpc could in principle occur at earlier stages, and that the arrowsmay correspond to direc
visceral endoderm; epc, ectoplacental cone; epi, epiblast; exe, extraembryonic ectoderm; mexpression at 5.5 dpc, which are believed to drive DVE movement
(Yamamoto et al., 2004). However, the ability of Cripto mutants to
form a partial DVE is likely to result from the activity of Cryptic
expressed in the proximal visceral endoderm.
The lack of overlapping expression for Cripto and Cryptic is
particularly striking given the multiple phenotypes of Cripto; Cryptic
double mutants that are not observed in the individual single
mutants. Thus, the ability of Cryptic expressed in the visceral
endoderm to promote formation of a DVE (albeit defective) in Cripto
mutants presumably reﬂects a cell-autonomous activity of Cryptic. In
contrast, the ability of Cripto expressed in the epiblast to promote
normal AVE formation and movement in Cryptic mutants would be
non-cell-autonomous. Moreover, the ability of Cryptic to promote
epiblast maintenance in the absence of Cripto is presumably non-cell-
autonomous, since Cryptic is only expressed in the visceral endoderm.
Finally, neither Cripto nor Cryptic are expressed in the ExE, yet these
two genes are required for maintenance of undifferentiated ExE. The
simplest explanation for these observations is that both Cripto and
Cryptic act non-cell-autonomously during early embryogenesis, as
previously shown for Cripto in axial mesendoderm formation during
gastrulation (Chu et al., 2005), and more generally in embryonic
development (Xu et al., 1999). Thus, we propose that Cripto and/or
Cryptic act non-cell-autonomously in distinct contexts in epiblast
maintenance, ExE maintenance, and AVE formation and movement
(Fig. 6).
In principle, these non-cell-autonomous functions of Cripto and
Cryptic could reﬂect direct or indirect mechanisms. In the former
situation, EGF-CFC proteins could be released from cells of one tissue
and act in a paracrine manner on cells of a neighboring tissue. In the
latter case, downstream targets of Cripto or Cryptic could mediate the
relevant intercellular interactions. In the case of Cripto, our geneticrams of the phenotype of wild-type, Cryptic null mutant, Cripto null mutant, and Cripto;
FC activity are shown (arrows). Note that the proposed signaling interactions shown at
t or indirect signaling events. Abbreviations: ave, anterior visceral endoderm; dve, distal
es, mesoderm.
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function of Cripto in axial mesendoderm reﬂects a direct, trans-acting
activity of Cripto protein, thus favoring the ﬁrst model (Chu et al.,
2005). However, it remains unclear whether the roles of EGF-CFC
proteins in visceral endoderm and the ExE are direct or indirect,
particularly since their temporal requirements during embryogenesis
are also unknown. Perhaps consistent with a direct role, Lefty1 is
expressed normally in the DVE of Cryptic null mutants at 5.5 dpc
(Fig. 5Q), which is notable since the relevant Lefty1 promoter element
contains essential FoxH1 binding sites, indicating that it is responsive
to Nodal signaling (Takaoka et al., 2006). Also favoring a direct role for
EGF-CFC proteins, weak phospho-Smad2 immunoreactivity can be
detected in the ExE at 5.5 dpc, and is abolished by culture in the
presence of the ALK4/ALK5/ALK7 inhibitor SB431542 (Yamamoto et
al., 2009). On the other hand, this phospho-Smad2 immunoreactivity
may be due to a different TGFβ signaling factor that does not require
EGF-CFC activity, such as Activin. Indeed, a recent study has suggested
that Activin, but not Nodal, is required for ExE as well as trophoblast
stem cell maintenance, and that the ExE requirement for Nodal (and
presumably EGF-CFC) function may reﬂect an autoregulatory loop for
epiblast expression of FGF4, which in turn acts as a paracrine signal to
the ExE (Natale et al., 2009).
Although EGF-CFC proteins were originally identiﬁed as strictly cis-
acting co-receptors for Nodal ligands that act cell-autonomously in
zebraﬁsh (Gritsman et al., 1999; Schier et al., 1997; Strahle et al., 1997),
there is considerable evidence for their trans-acting functions in cell
culture and in vivo (Chu et al., 2005; Minchiotti et al., 2001; Parisi et al.,
2003; Yan et al., 2002). For example, overexpression of a truncated form
of zebraﬁsh Oep that lacks the C-terminal GPI anchor in the
extraembryonic yolk syncytial layer can rescue the embryonic defects
of oep mutants, indicating non-autonomous function (Gritsman et al.,
1999; Minchiotti et al., 2001). In principle, such paracrine responses to
Cripto can be due to activation of the Nodal pathway, or can be Nodal-
independent in other contexts (Bianco et al., 2002; Bianco et al., 2003).
Cripto can be released from the cell membrane after cleavage of its
GPI-linkage by GPI–phospholipase D (Minchiotti et al., 2000;Watanabe
et al., 2007), while activity of human Cryptic is modulated by a
C-terminal hydrophilic extension that can lead to formation of both
GPI-linked and soluble forms of the protein (Watanabe et al., 2008).
However, the resulting soluble EGF-CFC proteinsmay be less efﬁcient at
signaling since they compete for Nodal bindingwith secreted inhibitors
(Blanchet et al., 2008; Constam, 2009). Thus, paracrine activity of Cripto
and Cryptic may be tightly regulated by Cerl as well as Lefty; notably,
Lefty proteins can also interact directly with EGF-CFC proteins (Chen
and Shen, 2004; Cheng et al., 2004).
Partial functional redundancy of EGF-CFC genes in mediating Nodal
signaling
Our ﬁndings demonstrate the strong similarity of the Cripto;
Cryptic double mutant phenotype to the Nodal null phenotype. These
Nodal mutant phenotypes include the defective maintenance of the
extraembryonic ectoderm (Brennan et al., 2001; Guzman-Ayala et al.,
2004), as well as the precocious neural differentiation of epiblast
(Camus et al., 2006), which is related to a requirement for epiblast
proliferation and size control in vivo (Mesnard et al., 2006).
Furthermore, Nodal signaling is required for maintenance of undif-
ferentiated human ES cells andmouse epiblast stem cells (Brons et al.,
2007; James et al., 2005; Tesar et al., 2007), most likely through up-
regulation of Nanog expression (Vallier et al., 2009; Xu et al., 2008). In
each case, the Nodalmutant phenotype is highly similar to the Cripto;
Cryptic double mutant phenotype, supporting the conclusion that
EGF-CFC proteins mediate all aspects of Nodal signaling in vivo.
Our results are relevant for previous studies that have addressed
whether Nodal signaling always requires EGF-CFC function. For
example, one recent study showed that puriﬁed Nodal precursorprotein can act on ExE explants, which lack EGF-CFC expression,
suggesting that Nodal precursor signals from the epiblast to the ExE in
an EGF-CFC independent manner (Ben-Haim et al., 2006). However, an
alternative explanation for this observation is that these ExE explants
may have already been “primed” for Nodal responsiveness by paracrine
Cripto and Cryptic by 5.5 dpc, and might not require EGF-CFC activity
thereafter. Furthermore, our results can also account for the Cripto-
independent Nodal signaling that was deduced from the ability of a Cerl
null mutant to partially suppress the Criptomutant phenotype (Liguori
et al., 2008). In this case, we propose that the removal of a Nodal
antagonist in Cripto; Cerl double mutants may result in greater range
and/or activity of Nodal protein and possibly of trans-acting Cryptic
protein as well. Thus, in the absence of Cerl, Nodal could mediate
Cryptic-dependent rescue of the Criptomutant phenotype.
Although Cripto and Cryptic display functional redundancy, our
ﬁndings suggest that their activities are not wholly equivalent. The
embryonic lethality of Cripto null mutants suggests that Cripto is more
essential than Cryptic, and therefore that Cripto may be more
important than Cryptic in mediating Nodal function, a conclusion
that is also consistent with the observed haploinsufﬁciency of Cryptic
in the absence of Cripto function. This difference between Cripto and
Cryptic may simply be due to relative differences in expression levels,
or the expression of Cripto in the epiblast, where the requirement for
mediating Nodal activity is greatest. Alternatively, this difference may
reﬂect a mechanistic distinction between Cripto and Cryptic with
respect to their non-autonomous activities.
Our ﬁndings are also relevant for assessing whether EGF-CFC
proteins may have activities that are independent of Nodal in early
embryogenesis. In particular, recent work has shown that EGF-CFC
proteins can mediate signaling by additional TGFβ ligands during
early vertebrate embryogenesis (Chen et al., 2006; Cheng et al., 2003).
One of these TGFβ ligands, GDF3 (Growth-Differentiation Factor-3),
has a Nodal-like activity in Xenopus embryos as well as EGF-CFC-
dependent signaling activity in cell culture, while Gdf3 null mutants
display phenotypes resembling those of Nodal hypomorphs (Anders-
son et al., 2007, 2008; Chen et al., 2006); however, we note that other
studies in Xenopus embryos have concluded that GDF3 primarily acts
as a BMP inhibitor in vivo (Levine and Brivanlou, 2006; Levine et al.,
2009). Furthermore, the TGFβ ligand GDF1 also stimulates Nodal
pathway activity in an EGF-CFC-dependent manner (Andersson et al.,
2006; Cheng et al., 2003), and can heterodimerize with Nodal to
potentiate Nodal activity, possibly by increasing long-range signaling
(Tanaka et al., 2007).
Finally, it remains conceivable that EGF-CFC proteins may have
activities that are entirely independent of the TGFβ/Activin/Nodal
pathway. For example, previous work has suggested a Nodal-indepen-
dent pathway that involves interaction of Cripto with glypican-1 and
subsequent activation of c-Src inmammary epithelial cells (Bianco et al.,
2003),while a recent studyhas shown thatCripto can facilitate signaling
throughNotch receptors in embryonal carcinoma cells (Watanabe et al.,
2009). In addition, Cripto and the Xenopus EGF-CFC protein FRL-1 have
been proposed to mediate signaling by Wnt11 through the canonical
Wnt/β-catenin signaling pathway (Tao et al., 2005). Notably, the
analysis of a Cripto hypomorphic allele containing a pointmutation that
eliminates activity in cell culture assays forNodal functionhas suggested
that many of the in vivo functions of Cripto are due to Nodal pathway-
independent activities (D'Andrea et al., 2008). However, given the
overall similarity of the Cripto; Cryptic double mutant phenotype with
that of Nodal null mutants, if such Nodal pathway-independent
activities of EGF-CFC proteins occur during early embryogenesis, they
should be largely redundant with Nodal pathway activity. Of course,
these data do not exclude the possibility that EGF-CFC proteins may
have Nodal pathway-independent activities at later stages of develop-
ment, or in cancer or other disease processes. Investigation of such
Nodal-independent EGF-CFC functions will be of continuing interest in
future studies.
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